The poorest OS was observed among the stage II/III colon cancer patients with the XRCC1 Gln allelic variants (HR  = 1.69, 95% CI  = 1.06–2.71, P  = 0.028, FDR  = 0.252). Here, XRCC1 is linked to malignant colon neoplasm.